论文部分内容阅读
目的:观察丹红注射液联合低分子肝素治疗不稳定心绞痛的临床疗效。方法:将患者随机分成治疗组(常规治疗组加用丹红注射液及低分子肝素)50例,对照组常规治疗分子50例,分别治疗14天后观察临床疗效及心电图。结果:治疗组在临床疗效改善方面优于对照组,差异显著(P<0.05)。心电图改善,治疗组优于对照组,但无显著差异。治疗组未发现不良反应。结论:丹红注射液联合低分子肝素治疗不稳定心绞痛安全有效。
Objective: To observe the clinical efficacy of Danhong injection combined with low molecular weight heparin in the treatment of unstable angina pectoris. Methods: The patients were randomly divided into treatment group (conventional treatment group plus Danhong injection and low molecular weight heparin) 50 cases, 50 cases of conventional treatment of the control group, respectively, after 14 days of treatment to observe the clinical efficacy and ECG. Results: The treatment group was better than the control group in improving the clinical curative effect, the difference was significant (P <0.05). ECG improved, treatment group than the control group, but no significant difference. The treatment group found no adverse reactions. Conclusion: Danhong injection combined with low molecular weight heparin in the treatment of unstable angina pectoris is safe and effective.